Parallel Advisors, LLC - DICERNA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$4,000
-55.6%
200
-16.0%
0.00%
Q2 2021$9,000
+80.0%
238
+19.0%
0.00%
Q1 2021$5,000
+25.0%
2000.0%0.00%
Q4 2020$4,0000.0%2000.0%0.00%
Q3 2020$4,000
-20.0%
2000.0%0.00%
Q2 2020$5,000
-83.9%
200
-90.0%
0.00%
-100.0%
Q3 2018$31,0002,0000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders